E. Tate

441 total citations
18 papers, 310 citations indexed

About

E. Tate is a scholar working on Neurology, Rheumatology and Psychiatry and Mental health. According to data from OpenAlex, E. Tate has authored 18 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 11 papers in Rheumatology and 4 papers in Psychiatry and Mental health. Recurrent topics in E. Tate's work include Glycogen Storage Diseases and Myoclonus (11 papers), Autoimmune Neurological Disorders and Treatments (10 papers) and Neurological disorders and treatments (6 papers). E. Tate is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (11 papers), Autoimmune Neurological Disorders and Treatments (10 papers) and Neurological disorders and treatments (6 papers). E. Tate collaborates with scholars based in United States, Switzerland and Czechia. E. Tate's co-authors include Michael R. Pranzatelli, David Neal Franz, Tyler Allison, Anna L. Travelstead, S J Verhulst, Edward J. Moticka, Julie T. Parke, David A. Stumpf, A. Pascual–Leone and Mark Hallett and has published in prestigious journals such as Neurology, Annals of Neurology and Anesthesiology.

In The Last Decade

E. Tate

18 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Tate United States 7 237 136 60 49 35 18 310
Saeid Mojtahedi United States 8 303 1.3× 42 0.3× 45 0.8× 92 1.9× 29 0.8× 15 460
Atsushi Kanoke Japan 10 167 0.7× 172 1.3× 23 0.4× 18 0.4× 17 0.5× 24 336
T Mannen Japan 11 179 0.8× 57 0.4× 19 0.3× 102 2.1× 30 0.9× 32 339
Sasha Burn United Kingdom 8 125 0.5× 40 0.3× 16 0.3× 93 1.9× 31 0.9× 18 299
D. Lorenz Germany 8 447 1.9× 54 0.4× 27 0.5× 240 4.9× 40 1.1× 12 512
Liam Carroll United Kingdom 5 63 0.3× 279 2.1× 119 2.0× 33 0.7× 23 0.7× 10 475
P Peretti-Viton France 10 92 0.4× 38 0.3× 21 0.3× 27 0.6× 108 3.1× 17 347
Sarah Louis France 10 146 0.6× 113 0.8× 19 0.3× 67 1.4× 13 0.4× 19 431
Maryline Carneiro France 7 167 0.7× 53 0.4× 40 0.7× 32 0.7× 12 0.3× 10 238
Gakushi Yoshikawa Japan 10 161 0.7× 27 0.2× 13 0.2× 42 0.9× 37 1.1× 38 305

Countries citing papers authored by E. Tate

Since Specialization
Citations

This map shows the geographic impact of E. Tate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Tate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Tate more than expected).

Fields of papers citing papers by E. Tate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Tate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Tate. The network helps show where E. Tate may publish in the future.

Co-authorship network of co-authors of E. Tate

This figure shows the co-authorship network connecting the top 25 collaborators of E. Tate. A scholar is included among the top collaborators of E. Tate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Tate. E. Tate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Abdel‐Rehim, Mohamed, Héctor Zenil, Oghenejokpeme I. Orhobor, et al.. (2025). Scientific hypothesis generation by large language models: laboratory validation in breast cancer treatment. Journal of The Royal Society Interface. 22(227). 20240674–20240674. 2 indexed citations
2.
Pranzatelli, Michael R., Tyler Allison, Nathan R. McGee, & E. Tate. (2018). Cerebrospinal fluid γδ T cell frequency is age-related: a case–control study of 435 children with inflammatory and non-inflammatory neurological disorders. Clinical & Experimental Immunology. 193(1). 103–112. 4 indexed citations
3.
Pranzatelli, Michael R., E. Tate, & Tyler Allison. (2017). 6-Mercaptopurine modifies cerebrospinal fluid T cell abnormalities in paediatric opsoclonus–myoclonus as steroid sparer. Clinical & Experimental Immunology. 190(2). 217–225. 6 indexed citations
4.
Pranzatelli, Michael R., E. Tate, Nathan R. McGee, et al.. (2013). Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus–myoclonus syndrome. Clinical & Experimental Immunology. 172(3). 427–436. 15 indexed citations
5.
Lee, Dawn, et al.. (2012). PCN70 The Cost Effectiveness of Degarelix for the Treatment of Prostate Cancer in the UK. Value in Health. 15(7). A421–A421. 2 indexed citations
6.
Fisher, Dean, et al.. (2011). PCN100 A Cost–Utility Analysis of Degarelix in the Treatment of Advanced Hormone-Dependent Prostate Cancer in Scotland. Value in Health. 14(7). A452–A452. 4 indexed citations
7.
Pranzatelli, Michael R., et al.. (2008). Neurometabolic Effects of ACTH on Free Amino Compounds in Opsoclonus-myoclonus Syndrome. Neuropediatrics. 39(3). 164–171. 4 indexed citations
8.
Pranzatelli, Michael R., et al.. (2006). CHARACTERIZING NEUROCOGNITIVE AND BEHAVIORAL FUNCTIONING IN PEDIATRIC OPSOCLONUS-MYOCLONUS SYNDROME (OMS). Neuropediatrics. 37(S 1). 1 indexed citations
9.
Pranzatelli, Michael R., Anna L. Travelstead, E. Tate, et al.. (2004). B- and T-cell markers in opsoclonus–myoclonus syndrome. Neurology. 62(9). 1526–1532. 125 indexed citations
10.
Pranzatelli, Michael R., Anna L. Travelstead, E. Tate, et al.. (2004). B- and t-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. American Journal of Ophthalmology. 138(2). 319–319. 7 indexed citations
11.
Pranzatelli, Michael R., et al.. (1996). A controlled trial of 5-hydroxy-l-tryptophan for ataxia in progressive myoclonus epilepsy. Clinical Neurology and Neurosurgery. 98(2). 161–164. 1 indexed citations
12.
Pranzatelli, Michael R., E. Tate, Yuting Huang, et al.. (1995). Neuropharmacology of Progressive Myoclonus Epilepsy: Response to 5‐Hydroxy‐L‐Tryptophan. Epilepsia. 36(8). 783–791. 41 indexed citations
13.
Pranzatelli, Michael R., Yuting Huang, E. Tate, et al.. (1995). Cerebrospinal fluid 5‐hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus‐myoclonus syndrome. Annals of Neurology. 37(2). 189–197. 9 indexed citations
14.
Kaplan, Richard F., Michael R. Pranzatelli, Yonghua Huang, & E. Tate. (1994). THE EFFECT OF PROPOFOL ON MYOCLONUS AND CEREBROSPINAL FLUID MONOAMINE METABOLITES IN CHILDREN WITH OPSOCLONUS-MYOCLONUS. Anesthesiology. 81(SUPPLEMENT). A229–A229. 6 indexed citations
15.
Pranzatelli, Michael R., E. Tate, Yong Huang, & Maria Baldwin. (1994). Clinical Response to 5-Hydroxy-L-tryptophan in Chronic Pediatric Opsoclonus–Myoclonus. Clinical Neuropharmacology. 17(2). 103–116. 3 indexed citations
16.
Tate, E.. (1993). The Clinical Challenge pf Progressive Myoclonus Epilepsy. The Nurse Practitioner. 18(5). 25–28. 3 indexed citations
17.
Pranzatelli, Michael R., Pei-Chun Kao, E. Tate, et al.. (1993). Antibodies to ACTH in Opsoclonus-Myoclonus. Neuropediatrics. 24(3). 131–133. 7 indexed citations
18.
Toro, Camilo, A. Pascual–Leone, Günther Deuschl, et al.. (1993). Cortical tremor. Neurology. 43(11). 2346–2346. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saeid Mojtahedi Breakdown of academic impact, for papers by Atsushi Kanoke Breakdown of academic impact, for papers by T Mannen Breakdown of academic impact, for papers by Sasha Burn Breakdown of academic impact, for papers by D. Lorenz Breakdown of academic impact, for papers by Liam Carroll Breakdown of academic impact, for papers by P Peretti-Viton Breakdown of academic impact, for papers by Sarah Louis Breakdown of academic impact, for papers by Maryline Carneiro Breakdown of academic impact, for papers by Gakushi Yoshikawa
Rankless by CCL
2026